SLFN12 and prostate carcinoma: Although this SLFN12 study did not conduct survival analysis in prostate cancer, better differentiation of cancer cells is known to have a better outcome; therefore, SLFN12 expression is predicted to correlate with better prostate cancer outcomes [92].